File(s) under permanent embargo

Reason: Under embargo until February 2022. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library, or by emailing

Towards optimal utilisation of technology in type 1 diabetes mellitus from a clinical and Australian health economic perspective

posted on 02.02.2021, 03:38 by ANTHONY JAMES PEASE
Type 1 diabetes is difficult to manage and is characterised by insulin deficiency and high blood glucose levels (BGLs). Complications include cardiovascular disease (CVD) and premature mortality. In this thesis, approaches to reducing CVD were appraised and multiple technologies were compared for BGL control and the prevention of complications. Duration of type 1 diabetes was important for predicting cardiovascular risk and new insulin delivery technologies were cost-effective. These results have underpinned new clinical recommendations on the use of technologies for people with type 1 diabetes and inform implementation strategies and future government policy.


Principal supervisor

Sophia Zoungas

Year of Award


Department, School or Centre

Public Health and Preventive Medicine


Doctor of Philosophy

Degree Type